| 4.6 -0.07 (-1.5%) | 07-18 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 6.34 | 1-year : | 7.4 |
| Resists | First : | 5.42 | Second : | 6.34 |
| Pivot price | 4.92 |
|||
| Supports | First : | 3.8  |
Second : | 2.79 |
| MAs | MA(5) : | 4.71 |
MA(20) : | 4.68 |
| MA(100) : | 2.9 |
MA(250) : | 3.02 |
|
| MACD | MACD : | 0.3 |
Signal : | 0.4 |
| %K %D | K(14,3) : | 45.8 |
D(3) : | 56.5 |
| RSI | RSI(14): 56.5 |
|||
| 52-week | High : | 5.88 | Low : | 1.29 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ SNES ] has closed above bottom band by 5.4%. Bollinger Bands are 35.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 4.8 - 4.83 | 4.83 - 4.86 |
| Low: | 4.45 - 4.48 | 4.48 - 4.51 |
| Close: | 4.54 - 4.6 | 4.6 - 4.65 |
SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Tue, 01 Jul 2025
SenesTech Announces Warrant Exercise for $4.4 Million in Gross Proceeds | SNES Stock News - GuruFocus
Tue, 01 Jul 2025
SenesTech Raises $4.4M Now, Eyes Additional $6M Through New Warrant Structure - Stock Titan
Tue, 01 Jul 2025
SenesTech Announces Warrant Exercise for $4.4 Million in Gross Proceeds - PR Newswire
Tue, 01 Jul 2025
SenesTech Raises $4.4M Now, Eyes Additional $6M in Strategic Warrant Exercise Deal - Stock Titan
Thu, 26 Jun 2025
Revolutionary Rat Birth Control Transforms Pest Control in Major Cities, Triggers Container-Size Orders - Stock Titan
Wed, 25 Jun 2025
SenesTech and Irvine Campus Housing Authority Conclude Successful Field Trial of Evolve™ Rat Birth Control at UC Irvine - PR Newswire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Basic Materials
|
|
|
Industry:
Chemicals - Specialty
|
|
| Shares Out | 2 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 5 (%) |
| Held by Institutions | 1.1 (%) |
| Shares Short | 328 (K) |
| Shares Short P.Month | 246 (K) |
| EPS | -6.58 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.62 |
| Profit Margin | 0 % |
| Operating Margin | -342.9 % |
| Return on Assets (ttm) | -83.4 % |
| Return on Equity (ttm) | -160.5 % |
| Qtrly Rev. Growth | 16.8 % |
| Gross Profit (p.s.) | 0.52 |
| Sales Per Share | 0.85 |
| EBITDA (p.s.) | -2.63 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -6 (M) |
| Levered Free Cash Flow | -4 (M) |
| PE Ratio | -0.7 |
| PEG Ratio | 0 |
| Price to Book value | 2.82 |
| Price to Sales | 5.36 |
| Price to Cash Flow | -1.8 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|